Specificity | Clone | Host Species | Reactive Species | Format | Size | Reviews | Supplier | |
---|---|---|---|---|---|---|---|---|
SARS-CoV-2 NSP1 | polyclonal | Goat | SARS coronavirus (SARS-CoV-2) | unconjugated | 300 µg | n/a |
ANTIBODIES-ONLINE GmbH |
More Info |
SARS-CoV-2 NSP1 | polyclonal | Rabbit | SARS coronavirus (SARS-CoV-2) | unconjugated | 0.1 mg | n/a |
ANTIBODIES-ONLINE GmbH |
More Info |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Glycoprotein | polyclonal | Rabbit | n/a | immunogen affinity purified | 30 µl, 100 µl, 1 ml, | n/a |
ABBEXA LTD |
More Info |
SARS-CoV-2 (Bamlanivimab biosimilar) | monoclonal | n/a | human | Protein A/G purified, low endotoxin | 100mg | n/a |
ICHORBIO |
More Info |
SARS-CoV-2 (Bamlanivimab biosimilar) | monoclonal | n/a | human | Protein A/G purified, low endotoxin | 10mg | n/a |
ICHORBIO |
More Info |
SARS-CoV-2 (Bamlanivimab biosimilar) | monoclonal | n/a | human | Protein A/G purified, low endotoxin | 1mg | n/a |
ICHORBIO |
More Info |
SARS-CoV-2 (Bamlanivimab biosimilar) | monoclonal | n/a | human | Protein A/G purified, low endotoxin | 20mg | n/a |
ICHORBIO |
More Info |
SARS-CoV-2 (Bamlanivimab biosimilar) | monoclonal | n/a | human | Protein A/G purified, low endotoxin | 50mg | n/a |
ICHORBIO |
More Info |
SARS-CoV-2 (Bamlanivimab biosimilar) | monoclonal | n/a | human | Protein A/G purified, low endotoxin | 5mg | n/a |
ICHORBIO |
More Info |
SARS-CoV-2 Spike RBD | 2165 | Recombinant | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 Spike RBD | 2196 | Recombinant | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 Spike RBD | 2355 | Recombinant | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 Spike RBD | 2381 | Recombinant | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 Spike RBD | 2838 | Recombinant | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 Variants (Omicron) NP | monoclonal | Recombinant Mouse | SARS-CoV-2 and SARS-CoV-2 Omicron (B.1.1.529) Variant. | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 NSP14 | polyclonal | Goat | SARS coronavirus (SARS-CoV-2) | unconjugated | 300 µg | n/a |
ANTIBODIES-ONLINE GmbH |
More Info |
SARS-CoV-2 NSP14 | polyclonal | Rabbit | SARS coronavirus (SARS-CoV-2) | unconjugated | 0.1 mg | n/a |
ANTIBODIES-ONLINE GmbH |
More Info |
SARS-CoV-2 NSP14 | polyclonal | Rabbit | SARS coronavirus (SARS-CoV-2) | unconjugated | 0.1 mg | n/a |
ANTIBODIES-ONLINE GmbH |
More Info |
SARS-CoV-2 (2019-nCoV) Nucleocapsid Protein SARS-CoV Nucleocapsid Protein | monoclonal | Recombinant Rabbit | SARS | Protein A purified | 100µL | n/a |
SINO BIOLOGICAL, INC. |
More Info |
SARS-CoV-2 (2019-nCoV) Nucleocapsid Protein SARS-CoV Nucleocapsid Protein | monoclonal | Recombinant Rabbit | SARS | biotin conjugate | 100µg | n/a |
SINO BIOLOGICAL, INC. |
More Info |
SARS-CoV-2 RBD (Etesevimab biosimilar) | monoclonal | Recombinant Human | human | Protein A/G purified | 100 µg, 1 mg, | n/a |
ABBEXA LTD |
More Info |
SARS-CoV-2 Spike (Bamlanivimab biosimilar) | monoclonal | Recombinant Human | human | Protein A/G purified | 100 µg, 1 mg, | n/a |
ABBEXA LTD |
More Info |
2019-nCoV NP | monoclonal | Recombinant Human | SARS-CoV-2 (2019-nCoV) | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
2019-nCoV NP | monoclonal | Recombinant Human | SARS-CoV-2 (2019-nCoV) | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 NP | monoclonal | Recombinant Human | SARS-CoV-2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 NP | monoclonal | Recombinant Mouse | SARS-CoV-2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
S1 SARS-CoV-2 | W25 | Recombinant Rabbit | n/a | unconjugated | 100 µg | n/a |
SYNAPTIC SYSTEMS GmbH |
More Info |
S1 SARS-CoV-2 | W25 | Camelid | n/a | single domain-ATTO 488 conjugate | 200 µl | n/a |
SYNAPTIC SYSTEMS GmbH |
More Info |
S1 SARS-CoV-2 | W25 | Camelid | n/a | single domain-AZdye 568 conjugate | 200 µl | n/a |
SYNAPTIC SYSTEMS GmbH |
More Info |
S1 SARS-CoV-2 | W25 | Camelid | n/a | single domain-Alexa Fluor 647 conjugate | 200 µl | n/a |
SYNAPTIC SYSTEMS GmbH |
More Info |
S1 SARS-CoV-2 | W25 | Camelid | n/a | single domain-unconjugated | 250 µg | n/a |
SYNAPTIC SYSTEMS GmbH |
More Info |
S1 SARS-CoV-2 | W25 | Camelid | n/a | single domain-DBCO conjugate | 250 µg | n/a |
SYNAPTIC SYSTEMS GmbH |
More Info |
S1 SARS-CoV-2 | W25 | Camelid | n/a | single domain-biotin conjugate | 250 µg | n/a |
SYNAPTIC SYSTEMS GmbH |
More Info |
SARS-CoV-2 Spike RBD | 2165 | Recombinant | n/a | biotin conjugate | 0.05 mg | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 Spike RBD | 2165 | Recombinant | n/a | peroxidase (HRP) conjugate | 0.05 mg | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 Spike RBD | 2196 | Recombinant | n/a | biotin conjugate | 0.05 mg | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 Spike RBD | 2196 | Recombinant | n/a | peroxidase (HRP) conjugate | 0.05 mg | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 ORF10 | polyclonal | Rabbit | SARS coronavirus (SARS-CoV-2) | unconjugated | 0.1 mg | n/a |
ANTIBODIES-ONLINE GmbH |
More Info |
SARS-CoV-2 ORF10 | polyclonal | Rabbit | SARS coronavirus (SARS-CoV-2) | unconjugated | 0.1 mg | n/a |
ANTIBODIES-ONLINE GmbH |
More Info |
SARS-CoV-2 ORF6 | polyclonal | Rabbit | SARS coronavirus (SARS-CoV-2) | unconjugated | 0.1 mg | n/a |
ANTIBODIES-ONLINE GmbH |
More Info |
SARS-CoV-2 ORF6 | polyclonal | Rabbit | SARS coronavirus (SARS-CoV-2) | unconjugated | 0.1 mg | n/a |
ANTIBODIES-ONLINE GmbH |
More Info |
SARS-CoV-2 ORF8 | polyclonal | Rabbit | SARS coronavirus (SARS-CoV-2) | unconjugated | 0.1 mg | n/a |
ANTIBODIES-ONLINE GmbH |
More Info |
SARS-CoV-2 S-NTD | monoclonal | Recombinant Human | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 Spike RBD (Casirivimab biosimilar) | monoclonal | Recombinant Human | human | Protein A/G purified | 100 µg, 1 mg, | n/a |
ABBEXA LTD |
More Info |
SARS-CoV-2 Spike RBD (Cilgavimab biosimilar) | monoclonal | Recombinant Human | human | Protein A/G purified | 100 µg, 1 mg, | n/a |
ABBEXA LTD |
More Info |
SARS-CoV-2 Spike RBD (Etesevimab biosimilar) | monoclonal | Recombinant Human | human | Protein A/G purified | 100 µg, 1 mg, | n/a |
ABBEXA LTD |
More Info |
SARS-CoV-2 Spike RBD (Imdevimab biosimilar) | monoclonal | Recombinant Human | human | Protein A/G purified | 100 µg, 1 mg, | n/a |
ABBEXA LTD |
More Info |
SARS-CoV-2 Spike RBD (Regdanvimab biosimilar) | monoclonal | Recombinant Human | human | Protein A/G purified | 100 µg, 1 mg, | n/a |
ABBEXA LTD |
More Info |
SARS-CoV-2 Spike RBD (Sotrovimab biosimilar) | monoclonal | Recombinant Human | human | Protein A/G purified | 100 µg, 1 mg, | n/a |
ABBEXA LTD |
More Info |
SARS-CoV-2 Spike RBD (Tixagevimab biosimilar) | monoclonal | Recombinant Human | human | Protein A/G purified | 100 µg, 1 mg, | n/a |
ABBEXA LTD |
More Info |
SARS-CoV-2 (2019-nCoV) NP | monoclonal | Recombinant Rabbit | SARS-CoV-2 (2019-nCoV), SARS-CoV | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV & CoV-2 NP | 88 | Mouse | n/a | purified | 100 ug | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV & CoV-2 NP | 102-7 | Mouse | n/a | purified | 100 ug | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV & CoV-2 NP | 109-5 | Mouse | n/a | purified | 100 ug | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV & CoV-2 NP | monoclonal | Mouse | n/a | purified | 50 ug | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV & CoV-2 NP | monoclonal | Mouse | n/a | unconjugated | 50 ug | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV & CoV-2 NP | monoclonal | Mouse | n/a | purified | 100 ug | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV & CoV-2 Spike | CR3022 | Mouse | n/a | purified | 100 ug | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV & CoV-2 Spike | CR3022 | Mouse | n/a | purified | 100 ug | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV & CoV-2 Spike | CR3022 | Mouse | n/a | unconjugated | 100 ug | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 NP | polyclonal | Chicken | SARS-CoV-2 | unconjugated | n/a | n/a |
ST JOHN'S LABORATORY |
More Info |
NSP2 (SARS-CoV-2) | polyclonal | Goat | SARS-CoV-2 | epitope affinity purified | 300 µg | n/a |
SICGEN ANTIBODIES |
More Info |
SARS-CoV-2 RBD | monoclonal | Recombinant Human | SARS-CoV-2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 RBD | monoclonal | Recombinant Mouse | SARS-CoV-2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 RBD | monoclonal | Human | n/a | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 S | monoclonal | Recombinant Synthetic construct | SARS-CoV-2 | single domain | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 Spike | monoclonal | Recombinant Rabbit | SARS-CoV-2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 Spike | monoclonal | Recombinant Rabbit | SARS-CoV-2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 Spike | polyclonal | n/a | n/a | unconjugated | 200 ul, 100 ul, 50 ul | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 Spike | polyclonal | Rabbit | n/a | unconjugated | 100 ul, 50 ul, 100 ug, 50 ug | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 S RBD | monoclonal | Recombinant Human | SARS-CoV, SARS-CoV-2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 Spike | polyclonal | Human | SARS coronavirus (SARS-CoV-2) | biotin conjugate | 0.1 mg | n/a |
ANTIBODIES-ONLINE GmbH |
More Info |
SARS-CoV-2 Spike | polyclonal | Human | SARS coronavirus (SARS-CoV-2) | biotin conjugate | 0.1 mg | n/a |
ANTIBODIES-ONLINE GmbH |
More Info |
SARS-CoV-2 Spike | polyclonal | Rabbit | SARS coronavirus (SARS-CoV-2) | biotin conjugate | 0.1 mg | n/a |
ANTIBODIES-ONLINE GmbH |
More Info |
SARS-CoV-2 Spike | polyclonal | Rabbit | SARS coronavirus (SARS-CoV-2) | biotin conjugate | 0.1 mg | n/a |
ANTIBODIES-ONLINE GmbH |
More Info |